175 related articles for article (PubMed ID: 17895790)
1. [18F]Fluoro-L-dopa PET/CT in congenital hyperinsulinism.
Subramaniam RM; Karantanis D; Peller PJ
J Comput Assist Tomogr; 2007; 31(5):770-2. PubMed ID: 17895790
[TBL] [Abstract][Full Text] [Related]
2. 18F-DOPA positron emission tomography/computed tomography application in congenital hyperinsulinism.
Yang J; Yuan L; Meeks JK; Zhang N; Li C; Hao R
J Pediatr Endocrinol Metab; 2012; 25(7-8):619-22. PubMed ID: 23155683
[TBL] [Abstract][Full Text] [Related]
3. The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy.
Zani A; Nah SA; Ron O; Totonelli G; Ismail D; Smith VV; Ashworth M; Blankenstein O; Mohnike W; De Coppi P; Eaton S; Hussain K; Pierro A
J Pediatr Surg; 2011 Jan; 46(1):204-8. PubMed ID: 21238668
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism.
Barthlen W; Blankenstein O; Mau H; Koch M; Höhne C; Mohnike W; Eberhard T; Fuechtner F; Lorenz-Depiereux B; Mohnike K
J Clin Endocrinol Metab; 2008 Mar; 93(3):869-75. PubMed ID: 18073294
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography/computed tomography diagnostics by means of fluorine-18-L-dihydroxyphenylalanine in congenital hyperinsulinism.
Mohnike W; Barthlen W; Mohnike K; Blankenstein O
Semin Pediatr Surg; 2011 Feb; 20(1):23-7. PubMed ID: 21186000
[TBL] [Abstract][Full Text] [Related]
6. The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children.
Ribeiro MJ; Boddaert N; Bellanné-Chantelot C; Bourgeois S; Valayannopoulos V; Delzescaux T; Jaubert F; Nihoul-Fékété C; Brunelle F; De Lonlay P
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2120-8. PubMed ID: 17661030
[TBL] [Abstract][Full Text] [Related]
7. Fluorine-18 L-3,4-dihydroxyphenylalanine positron emission tomography: improving surgery and outcome in focal hyperinsulinism. Commentary to Mohnike et al.: Proposal for a standardized protocol for F-DOPA-PET (PET/CT) in congenital hyperinsulinism (Horm Res 2006;66:40-42).
Shield JP
Horm Res; 2006; 66(1):43-4. PubMed ID: 16710095
[No Abstract] [Full Text] [Related]
8. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA.
Ribeiro MJ; De Lonlay P; Delzescaux T; Boddaert N; Jaubert F; Bourgeois S; Dollé F; Nihoul-Fékété C; Syrota A; Brunelle F
J Nucl Med; 2005 Apr; 46(4):560-6. PubMed ID: 15809476
[TBL] [Abstract][Full Text] [Related]
9. Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism.
Capito C; Khen-Dunlop N; Ribeiro MJ; Brunelle F; Aigrain Y; Crétolle C; Jaubert F; De Lonlay P; Nihoul-Fékété C
Radiology; 2009 Oct; 253(1):216-22. PubMed ID: 19709999
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan.
Hardy OT; Hernandez-Pampaloni M; Saffer JR; Suchi M; Ruchelli E; Zhuang H; Ganguly A; Freifelder R; Adzick NS; Alavi A; Stanley CA
J Pediatr; 2007 Feb; 150(2):140-5. PubMed ID: 17236890
[TBL] [Abstract][Full Text] [Related]
11. Congenital hyperinsulinism: pancreatic [18F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion.
de Lonlay P; Simon-Carre A; Ribeiro MJ; Boddaert N; Giurgea I; Laborde K; Bellanné-Chantelot C; Verkarre V; Polak M; Rahier J; Syrota A; Seidenwurm D; Nihoul-Fékété C; Robert JJ; Brunelle F; Jaubert F
J Clin Endocrinol Metab; 2006 Mar; 91(3):933-40. PubMed ID: 16403819
[TBL] [Abstract][Full Text] [Related]
12. 18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: initial UK experience from a technologist's perspective.
Meintjes M; Endozo R; Dickson J; Erlandsson K; Hussain K; Townsend C; Menezes L; Bomanji J
Nucl Med Commun; 2013 Jun; 34(6):601-8. PubMed ID: 23571817
[TBL] [Abstract][Full Text] [Related]
13. The role of
Chroustova D; Trnka J; Pudlac A; Obermannova B; Lambert L
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(5):279-283. PubMed ID: 32448747
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography in congenital hyperinsulinism.
Mathur NB; Sharma M; Agarwal A; Kumar A
Indian Pediatr; 2011 Feb; 48(2):139-41. PubMed ID: 21378423
[TBL] [Abstract][Full Text] [Related]
15. Proposal for a standardized protocol for 18F-DOPA-PET (PET/CT) in congenital hyperinsulinism.
Mohnike K; Blankenstein O; Christesen HT; De Lonlay J; Hussain K; Koopmans KP; Minn H; Mohnike W; Mutair A; Otonkoski T; Rahier J; Ribeiro M; Schoenle E; Fékété CN
Horm Res; 2006; 66(1):40-2. PubMed ID: 16710094
[No Abstract] [Full Text] [Related]
16. ¹⁸F-DOPA PET/computed tomography imaging.
Chondrogiannis S; Marzola MC; Rubello D
PET Clin; 2014 Jul; 9(3):307-21. PubMed ID: 25030394
[TBL] [Abstract][Full Text] [Related]
17. Congenital hyperinsulinism treated by surgical resection of the hyperplastic lesion which had been preoperatively diagnosed by 18F-DOPA PET examination in Japan: a nationwide survey.
Kanamori Y; Watanabe T; Yorifuji T; Masue M; Sasaki H; Nio M
Pediatr Surg Int; 2018 Oct; 34(10):1093-1098. PubMed ID: 30076450
[TBL] [Abstract][Full Text] [Related]
18. Role of 18F-DOPA PET/CT imaging in congenital hyperinsulinism.
Ismail D; Hussain K
Rev Endocr Metab Disord; 2010 Sep; 11(3):165-9. PubMed ID: 20878481
[TBL] [Abstract][Full Text] [Related]
19. The diagnosis of ectopic focal hyperinsulinism of infancy with [18F]-dopa positron emission tomography.
Hussain K; Seppänen M; Näntö-Salonen K; Adzick NS; Stanley CA; Thornton P; Minn H
J Clin Endocrinol Metab; 2006 Aug; 91(8):2839-42. PubMed ID: 16684819
[TBL] [Abstract][Full Text] [Related]
20. 18-F-L 3,4-Dihydroxyphenylalanine PET/Computed Tomography in the Management of Congenital Hyperinsulinism.
States LJ; Saade-Lemus S; De Leon DD
PET Clin; 2020 Jul; 15(3):349-359. PubMed ID: 32498990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
